Moreover, in HCC, TAMs express high levels of SLC40A1, a marker gene encoding ferroportin, which activates Toll-like receptor (TLR) stimulation to produce IL-1β, IL-6, and IL-23, thus shifting innate immunity processes toward tumor-favoring activity [183]. The gene discussed is IL6; the disease is hepatocellular carcinoma.